APAC Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Asia Pacific clinical diagnostics market will grow by 9.8% annually with a total addressable market cap of USD 257.46 billion over 2022-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.

Highlighted with 30 tables and 59 figures, this 114-page report Asia Pacific Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.

Based on Test, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Lipid Panel

Infectious Disease Testing

Liver Panel

Complete Blood Count (CBC)

Electrolyte Testing

Renal Panel

Other Tests

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Instruments

Assay Kits & Reagents

Software & Services

By Indication the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Cardiovascular

Cancer

Infectious Disease

Stroke

Chronic Lower Respiratory Diseases

Diabetes

Other Indications

By Patient Gender the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Male Patients

Female Patients

By Age Group the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Age 44 and below

Age 45-64

Age 65 and over

By End User the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Hospital & Clinics Laboratory

Diagnostic Laboratory

Point-of-Care Testing

Other End Users

Geographically, the following national/local markets are fully investigated:

Japan

China

South Korea

Australia

India

Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Becton, Dickinson and Company

BioMerieux SA

Bio-Rad Laboratories Inc.

Bio-Reference Laboratories

Bioscientia Healthcare

Charles River Laboratories

Danaher Corporation

Hoffmann-La Roche AG

Hologic Inc.

Qiagen NV

Siemens Healthcare

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Selected Key Players:

Abbott Laboratories

Becton, Dickinson and Company

BioMerieux SA

Bio-Rad Laboratories Inc.

Bio-Reference Laboratories

Bioscientia Healthcare

Charles River Laboratories

Danaher Corporation

Hoffmann-La Roche AG

Hologic Inc.

Qiagen NV

Siemens Healthcare

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

Table of Contents

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 19

2.1 Market Size and Forecast 19

2.1.1 Impact of COVID-19 on World Economy 20

2.1.2 Impact of COVID-19 on the Market 22

2.2 Major Growth Drivers 24

2.3 Market Restraints and Challenges 30

2.4 Emerging Opportunities and Market Trends 33

2.5 Porter's Fiver Forces Analysis 37

3 Segmentation of Asia Pacific Market by Test 41

3.1 Market Overview by Test 41

3.2 Lipid Panel 43

3.3 Infectious Disease Testing 44

3.4 Liver Panel 45

3.5 Complete Blood Count (CBC) 46

3.6 Electrolyte Testing 47

3.7 Renal Panel 48

3.8 Other Tests 49

4 Segmentation of Asia Pacific Market by Product 50

4.1 Market Overview by Product 50

4.2 Instruments 52

4.3 Assay Kits & Reagents 53

4.4 Software & Services 54

5 Segmentation of Asia Pacific Market by Indication 55

5.1 Market Overview by Indication 55

5.2 Cardiovascular 57

5.3 Cancer 58

5.4 Infectious Disease 59

5.5 Stroke 60

5.6 Chronic Lower Respiratory Diseases 61

5.7 Diabetes 62

5.8 Other Indications 63

6 Segmentation of Asia Pacific Market by Patient Gender 64

6.1 Market Overview by Patient Gender 64

6.2 Male Patients 66

6.3 Female Patients 67

7 Segmentation of Asia Pacific Market by Age Group 68

7.1 Market Overview by Age Group 68

7.2 Age 44 and below 70

7.3 Age 45-64 71

7.4 Age 65 and over 72

8 Segmentation of Asia Pacific Market by End User 73

8.1 Market Overview by End User 73

8.2 Hospital & Clinics Laboratory 75

8.3 Diagnostic Laboratory 76

8.4 Point-of-Care Testing 77

8.5 Other End Users 78

9 Asia-Pacific Market 2021-2031 by Country 79

9.1 Overview of Asia-Pacific Market 79

9.2 Japan 82

9.3 China 85

9.4 Australia 87

9.5 India 90

9.6 South Korea 92

9.7 Rest of APAC Region 94

10 Competitive Landscape 96

10.1 Overview of Key Vendors 96

10.2 New Product Launch, Partnership, Investment, and M&A 99

10.3 Company Profiles 100

Abbott Laboratories 100

Becton, Dickinson and Company 102

BioMerieux SA 103

Bio-Rad Laboratories Inc. 104

Bio-Reference Laboratories 105

Bioscientia Healthcare 106

Charles River Laboratories 107

Danaher Corporation 108

Hoffmann-La Roche AG 109

Hologic Inc. 110

Qiagen NV 111

Siemens Healthcare 112

Thermo Fisher Scientific 113

RELATED REPORTS 114


List of Figure

List of Figures:

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16

Figure 4. Asia Pacific Clinical Diagnostics Market, 2021-2031, USD mn 19

Figure 5. Impact of COVID-19 on Business 22

Figure 6. Primary Drivers and Impact Factors of Asia Pacific Clinical Diagnostics Market 24

Figure 7. Leading Causes of Death in the World, 2019-2020, million 27

Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28

Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 28

Figure 10. Primary Restraints and Impact Factors of Asia Pacific Clinical Diagnostics Market 30

Figure 11. Investment Opportunity Analysis 34

Figure 12. Porter's Fiver Forces Analysis of Asia Pacific Clinical Diagnostics Market 37

Figure 13. Breakdown of Asia Pacific Clinical Diagnostics Market by Test, 2021-2031, % of Revenue 42

Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Test, Value (USD mn) and Share (%) 42

Figure 15. Asia Pacific Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, USD mn 43

Figure 16. Asia Pacific Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, USD mn 44

Figure 17. Asia Pacific Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, USD mn 45

Figure 18. Asia Pacific Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, USD mn 46

Figure 19. Asia Pacific Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, USD mn 47

Figure 20. Asia Pacific Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, USD mn 48

Figure 21. Asia Pacific Clinical Diagnostics Market by Test: Other Tests, 2021-2031, USD mn 49

Figure 22. Breakdown of Asia Pacific Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue 51

Figure 23. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 51

Figure 24. Asia Pacific Clinical Diagnostics Market by Product: Instruments, 2021-2031, USD mn 52

Figure 25. Asia Pacific Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, USD mn 53

Figure 26. Asia Pacific Clinical Diagnostics Market by Product: Software & Services, 2021-2031, USD mn 54

Figure 27. Breakdown of Asia Pacific Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue 56

Figure 28. Asia Pacific Addressable Market Cap in 2022-2031 by Indication, Value (USD mn) and Share (%) 56

Figure 29. Asia Pacific Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, USD mn 57

Figure 30. Asia Pacific Clinical Diagnostics Market by Indication: Cancer, 2021-2031, USD mn 58

Figure 31. Asia Pacific Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, USD mn 59

Figure 32. Asia Pacific Clinical Diagnostics Market by Indication: Stroke, 2021-2031, USD mn 60

Figure 33. Asia Pacific Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, USD mn 61

Figure 34. Asia Pacific Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, USD mn 62

Figure 35. Asia Pacific Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, USD mn 63

Figure 36. Breakdown of Asia Pacific Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue 65

Figure 37. Asia Pacific Addressable Market Cap in 2022-2031 by Patient Gender, Value (USD mn) and Share (%) 65

Figure 38. Asia Pacific Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, USD mn 66

Figure 39. Asia Pacific Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, USD mn 67

Figure 40. Breakdown of Asia Pacific Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue 69

Figure 41. Asia Pacific Addressable Market Cap in 2022-2031 by Age Group, Value (USD mn) and Share (%) 69

Figure 42. Asia Pacific Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, USD mn 70

Figure 43. Asia Pacific Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, USD mn 71

Figure 44. Asia Pacific Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, USD mn 72

Figure 45. Breakdown of Asia Pacific Clinical Diagnostics Market by End User, 2021-2031, % of Revenue 73

Figure 46. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 74

Figure 47. Asia Pacific Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, USD mn 75

Figure 48. Asia Pacific Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, USD mn 76

Figure 49. Asia Pacific Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, USD mn 77

Figure 50. Asia Pacific Clinical Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 78

Figure 51. Breakdown of APAC Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 80

Figure 52. Contribution to APAC 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 81

Figure 53. Clinical Diagnostics Market in Japan, 2021-2031, USD mn 83

Figure 54. Clinical Diagnostics Market in China, 2021-2031, USD mn 85

Figure 55. Clinical Diagnostics Market in Australia, 2021-2031, USD mn 87

Figure 56. Clinical Diagnostics Market in India, 2021-2031, USD mn 90

Figure 57. Clinical Diagnostics Market in South Korea, 2021-2031, USD mn 92

Figure 58. Clinical Diagnostics Market in Rest of APAC, 2021-2031, USD mn 94

Figure 59. Growth Stage of Asia Pacific Clinical Diagnostics Industry over the Forecast Period 96


List of Table

List of Tables:

Table 1. Snapshot of Asia Pacific Clinical Diagnostics Market in Balanced Perspective, 2021-2031 17

Table 2. World Economic Outlook, 2021-2031 21

Table 3. World Health Spending by Region, USD bn, 2013-2020 29

Table 4. Main Product Trends and Market Opportunities in Asia Pacific Clinical Diagnostics Market 33

Table 5. Asia Pacific Clinical Diagnostics Market by Test, 2021-2031, USD mn 41

Table 6. Asia Pacific Clinical Diagnostics Market by Product, 2021-2031, USD mn 50

Table 7. Asia Pacific Clinical Diagnostics Market by Indication, 2021-2031, USD mn 55

Table 8. Asia Pacific Clinical Diagnostics Market by Patient Gender, 2021-2031, USD mn 64

Table 9. Asia Pacific Clinical Diagnostics Market by Age Group, 2021-2031, USD mn 68

Table 10. Asia Pacific Clinical Diagnostics Market by End User, 2021-2031, USD mn 73

Table 11. APAC Clinical Diagnostics Market by Country, 2021-2031, USD mn 80

Table 12. Japan Clinical Diagnostics Market by Test, 2021-2031, USD mn 84

Table 13. Japan Clinical Diagnostics Market by Product, 2021-2031, USD mn 84

Table 14. Japan Clinical Diagnostics Market by Indication, 2021-2031, USD mn 84

Table 15. China Clinical Diagnostics Market by Test, 2021-2031, USD mn 86

Table 16. China Clinical Diagnostics Market by Product, 2021-2031, USD mn 86

Table 17. China Clinical Diagnostics Market by Indication, 2021-2031, USD mn 86

Table 18. Australia Clinical Diagnostics Market by Test, 2021-2031, USD mn 88

Table 19. Australia Clinical Diagnostics Market by Product, 2021-2031, USD mn 88

Table 20. Australia Clinical Diagnostics Market by Indication, 2021-2031, USD mn 88

Table 21. India Clinical Diagnostics Market by Test, 2021-2031, USD mn 91

Table 22. India Clinical Diagnostics Market by Product, 2021-2031, USD mn 91

Table 23. India Clinical Diagnostics Market by Indication, 2021-2031, USD mn 91

Table 24. South Korea Clinical Diagnostics Market by Test, 2021-2031, USD mn 93

Table 25. South Korea Clinical Diagnostics Market by Product, 2021-2031, USD mn 93

Table 26. South Korea Clinical Diagnostics Market by Indication, 2021-2031, USD mn 93

Table 27. Clinical Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, USD mn 95

Table 28. Abbott Laboratories: Company Snapshot 100

Table 29. Abbott Laboratories: Business Segmentation 101

Table 30. Abbott Laboratories: Product Portfolio 101

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us

Want the same for your business? Talk To Our Expert